# Coinbase timeline entity: /record/coinbase.md id: ent_coinbase ## undated - undated | cik | 0001679788 | valid | [clm_14897FFD6C93](/claim/clm_14897FFD6C93.md) - undated | registrant_name | Coinbase Global, Inc. | valid | [clm_3EBA78047508](/claim/clm_3EBA78047508.md) - undated | fiscal_year_end | 12-31 | valid | [clm_611033DA2BF8](/claim/clm_611033DA2BF8.md) - undated | state_of_incorporation | TX | valid | [clm_A91B28F3A34C](/claim/clm_A91B28F3A34C.md) - undated | ticker | COIN | valid | [clm_BB6008ECE44A](/claim/clm_BB6008ECE44A.md) - undated | sic_industry | Finance Services (6199) | valid | [clm_CE510187353C](/claim/clm_CE510187353C.md) ## 2012 - 2012-05-07 | x_username | coinbase | unverified | [clm_6B80CABCBA49](/claim/clm_6B80CABCBA49.md) ## undated - undated | country | United States | unverified | [clm_6D21CE668AB9](/claim/clm_6D21CE668AB9.md) - undated | legal_form | Delaware corporation | unverified | [clm_8CB68F6CD99B](/claim/clm_8CB68F6CD99B.md) - undated | website | https://www.coinbase.com | unverified | [clm_BD465C82F757](/claim/clm_BD465C82F757.md) ## 2014 - 2014-06-08 | x_username | CoinbaseSupport | unverified | [clm_1C77C5E92046](/claim/clm_1C77C5E92046.md) ## 2016 - 2016-04-14 | x_username | CoinbasePro | unverified | [clm_FB8F41628CE9](/claim/clm_FB8F41628CE9.md) - 2016-10-24 | x_username | CoinbaseWallet | unverified | [clm_98FE225F9659](/claim/clm_98FE225F9659.md) ## 2018 - 2018-01-11 | x_username | CommerceCB | unverified | [clm_45BEB787EE7B](/claim/clm_45BEB787EE7B.md) - 2018-09-01 to 2020-12-31 | employees | 1,123 | superseded | [clm_32E8D159E388](/claim/clm_32E8D159E388.md) - 2018-12-31 to 2019-12-31 | total_equity | 500,071,000 United States dollar | superseded | [clm_CB59718CBBF9](/claim/clm_CB59718CBBF9.md) ## 2019 - 2019-12-31 to 2020-12-31 | revenue | 533,735,000 United States dollar | superseded | [clm_116776A03D7B](/claim/clm_116776A03D7B.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 548,945,000 United States dollar | superseded | [clm_188DC5326844](/claim/clm_188DC5326844.md) - 2019-12-31 to 2020-12-31 | total_assets | 2,391,769,000 United States dollar | superseded | [clm_53D4E92AA5DE](/claim/clm_53D4E92AA5DE.md) - 2019-12-31 to 2020-12-31 | research_and_development | 185,044,000 United States dollar | superseded | [clm_5609D450882C](/claim/clm_5609D450882C.md) - 2019-12-31 to 2020-12-31 | operating_income | -45,783,000 United States dollar | superseded | [clm_A33DB680AF63](/claim/clm_A33DB680AF63.md) - 2019-12-31 to 2020-12-31 | net_income | -30,387,000 United States dollar | superseded | [clm_E82A868775A5](/claim/clm_E82A868775A5.md) - 2019-12-31 to 2020-03-31 | total_equity | 497,086,000 United States dollar | superseded | [clm_ED8079E2641C](/claim/clm_ED8079E2641C.md) ## 2020 - 2020-03-31 to 2020-06-30 | quarterly_operating_income | 38,775,000 United States dollar | superseded | [clm_18D319CA2702](/claim/clm_18D319CA2702.md) - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 47,138,000 United States dollar | superseded | [clm_56D3BEE695F3](/claim/clm_56D3BEE695F3.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | 31,973,000 United States dollar | superseded | [clm_741BD7206ABD](/claim/clm_741BD7206ABD.md) - 2020-03-31 to 2020-06-30 | total_equity | 537,913,000 United States dollar | superseded | [clm_AD5A6B595F96](/claim/clm_AD5A6B595F96.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 190,630,000 United States dollar | superseded | [clm_C0ECF4081EAA](/claim/clm_C0ECF4081EAA.md) - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 636,324,000 United States dollar | superseded | [clm_DB1DE2DC78DB](/claim/clm_DB1DE2DC78DB.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | 42,086,000 United States dollar | superseded | [clm_04C0F256C0AC](/claim/clm_04C0F256C0AC.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | 32,260,000 United States dollar | superseded | [clm_09651EACA8DE](/claim/clm_09651EACA8DE.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 687,410,000 United States dollar | superseded | [clm_432FAF1C7567](/claim/clm_432FAF1C7567.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 60,777,000 United States dollar | superseded | [clm_A9A6F95BF243](/claim/clm_A9A6F95BF243.md) - 2020-06-30 to 2020-09-30 | total_equity | 583,116,000 United States dollar | superseded | [clm_C180E108D461](/claim/clm_C180E108D461.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 186,382,000 United States dollar | superseded | [clm_C7C8EF1499B6](/claim/clm_C7C8EF1499B6.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | 101,505,000 United States dollar | superseded | [clm_304F72FA46A3](/claim/clm_304F72FA46A3.md) - 2020-09-30 to 2020-12-31 | total_equity | 735,611,000 United States dollar | superseded | [clm_48C3387F1AA6](/claim/clm_48C3387F1AA6.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 73,319,000 United States dollar | superseded | [clm_4EA47A6B8F5A](/claim/clm_4EA47A6B8F5A.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 766,262,000 United States dollar | superseded | [clm_5136D868E08A](/claim/clm_5136D868E08A.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 315,357,000 United States dollar | superseded | [clm_C1B64368726F](/claim/clm_C1B64368726F.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | 81,299,000 United States dollar | superseded | [clm_C9BA6C4C3ACB](/claim/clm_C9BA6C4C3ACB.md) - 2020-12-31 to 2021-03-31 | total_assets | 5,855,414,000 United States dollar | superseded | [clm_07FA61F3959E](/claim/clm_07FA61F3959E.md) - 2020-12-31 to 2021-12-31 | net_income | 322,317,000 United States dollar | superseded | [clm_137768E23DE4](/claim/clm_137768E23DE4.md) - 2020-12-31 to 2021-12-31 | operating_income | 408,951,000 United States dollar | superseded | [clm_4FA331466FE8](/claim/clm_4FA331466FE8.md) - 2020-12-31 to 2021-12-31 | research_and_development | 271,732,000 United States dollar | superseded | [clm_8E2DA68ED0DB](/claim/clm_8E2DA68ED0DB.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 1,061,850,000 United States dollar | superseded | [clm_C8440E1746A8](/claim/clm_C8440E1746A8.md) - 2020-12-31 to 2021-12-31 | revenue | 1,277,481,000 United States dollar | superseded | [clm_D917E105AF7D](/claim/clm_D917E105AF7D.md) - 2020-12-31 to 2021-03-31 | total_equity | 963,584,000 United States dollar | superseded | [clm_DEB3B5F101E8](/claim/clm_DEB3B5F101E8.md) - 2020-12-31 to 2025-12-31 | employees | 1,249 | superseded | [clm_E361A4B6A17E](/claim/clm_E361A4B6A17E.md) ## 2021 - 2021-03-15 | owned_by | Brian Armstrong | unverified | [clm_17DA698BEA8A](/claim/clm_17DA698BEA8A.md) - 2021-03-15 | owned_by | Andreessen Horowitz | unverified | [clm_E9A9587355B2](/claim/clm_E9A9587355B2.md) - 2021-03-15 | owned_by | Union Square Ventures | unverified | [clm_F7D62ACA4213](/claim/clm_F7D62ACA4213.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | 771,463,000 United States dollar | superseded | [clm_475B4D91F0F0](/claim/clm_475B4D91F0F0.md) - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 1,983,318,000 United States dollar | superseded | [clm_53E398B6C4B4](/claim/clm_53E398B6C4B4.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 184,225,000 United States dollar | superseded | [clm_5C112079C08F](/claim/clm_5C112079C08F.md) - 2021-03-31 to 2021-06-30 | total_assets | 10,201,112,000 United States dollar | superseded | [clm_7B5CFA7848E6](/claim/clm_7B5CFA7848E6.md) - 2021-03-31 to 2021-06-30 | total_equity | 2,304,408,000 United States dollar | superseded | [clm_872498B9CBCC](/claim/clm_872498B9CBCC.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | 987,713,000 United States dollar | superseded | [clm_B2A79472F544](/claim/clm_B2A79472F544.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 1,801,112,000 United States dollar | superseded | [clm_BF12C7B3353A](/claim/clm_BF12C7B3353A.md) - 2021-04-14 | listed_on | Nasdaq | valid | [clm_A56690D03983](/claim/clm_A56690D03983.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 2,227,962,000 United States dollar | superseded | [clm_2562209E6160](/claim/clm_2562209E6160.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 291,461,000 United States dollar | superseded | [clm_4078A2FEDA18](/claim/clm_4078A2FEDA18.md) - 2021-06-30 to 2021-09-30 | total_assets | 15,790,208,000 United States dollar | superseded | [clm_5915EEE1F93B](/claim/clm_5915EEE1F93B.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 4,365,982,000 United States dollar | superseded | [clm_5FB0201875BF](/claim/clm_5FB0201875BF.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | 1,606,349,000 United States dollar | superseded | [clm_A3F2F2C05D4E](/claim/clm_A3F2F2C05D4E.md) - 2021-06-30 to 2021-09-30 | total_equity | 4,623,425,000 United States dollar | superseded | [clm_F81968F58884](/claim/clm_F81968F58884.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | 874,725,000 United States dollar | superseded | [clm_F8638EECC92C](/claim/clm_F8638EECC92C.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 356,264,000 United States dollar | superseded | [clm_415F38B1EC79](/claim/clm_415F38B1EC79.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | 406,100,000 United States dollar | superseded | [clm_6EC26D9471F8](/claim/clm_6EC26D9471F8.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 1,311,908,000 United States dollar | superseded | [clm_9B00A58018F8](/claim/clm_9B00A58018F8.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 6,352,775,000 United States dollar | superseded | [clm_9FDAB825DF7B](/claim/clm_9FDAB825DF7B.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | 291,808,000 United States dollar | superseded | [clm_B90CF6034BDA](/claim/clm_B90CF6034BDA.md) - 2021-09-30 to 2021-12-31 | total_equity | 5,360,497,000 United States dollar | superseded | [clm_C0EB258EF200](/claim/clm_C0EB258EF200.md) - 2021-09-30 to 2021-12-31 | total_assets | 18,454,271,000 United States dollar | superseded | [clm_E57477772E1B](/claim/clm_E57477772E1B.md) - 2021-12-31 to 2022-12-31 | research_and_development | 1,291,561,000 United States dollar | superseded | [clm_2360365A0675](/claim/clm_2360365A0675.md) - 2021-12-31 to 2022-03-31 | total_equity | 6,381,689,000 United States dollar | superseded | [clm_242659723243](/claim/clm_242659723243.md) - 2021-12-31 to 2022-03-31 | total_assets | 21,274,425,000 United States dollar | superseded | [clm_2CD70B7D0B51](/claim/clm_2CD70B7D0B51.md) - 2021-12-31 to 2022-12-31 | revenue | 7,839,444,000 United States dollar | superseded | [clm_73A468D043D4](/claim/clm_73A468D043D4.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 7,123,478,000 United States dollar | superseded | [clm_C81A0DF2F749](/claim/clm_C81A0DF2F749.md) - 2021-12-31 to 2022-12-31 | operating_income | 3,076,570,000 United States dollar | superseded | [clm_D679077B87F9](/claim/clm_D679077B87F9.md) - 2021-12-31 to 2022-12-31 | net_income | 3,624,120,000 United States dollar | superseded | [clm_D87F36619294](/claim/clm_D87F36619294.md) ## 2022 - 2022-03-31 to 2022-06-30 | total_assets | 20,895,194,000 United States dollar | superseded | [clm_17C113A64B73](/claim/clm_17C113A64B73.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 1,166,436,000 United States dollar | superseded | [clm_587EFFFA2BD1](/claim/clm_587EFFFA2BD1.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -429,659,000 United States dollar | superseded | [clm_8F1731866E04](/claim/clm_8F1731866E04.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 570,664,000 United States dollar | superseded | [clm_952406DDAF13](/claim/clm_952406DDAF13.md) - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 6,116,388,000 United States dollar | superseded | [clm_96EBB6C7D360](/claim/clm_96EBB6C7D360.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -554,463,000 United States dollar | superseded | [clm_B0A2A0837C9A](/claim/clm_B0A2A0837C9A.md) - 2022-03-31 to 2022-06-30 | total_equity | 6,496,093,000 United States dollar | superseded | [clm_F8E757162AB2](/claim/clm_F8E757162AB2.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -1,044,389,000 United States dollar | superseded | [clm_0570BF560B74](/claim/clm_0570BF560B74.md) - 2022-06-30 to 2022-09-30 | total_equity | 5,813,389,000 United States dollar | superseded | [clm_4CB103642264](/claim/clm_4CB103642264.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 5,682,068,000 United States dollar | superseded | [clm_8B738E9E8F63](/claim/clm_8B738E9E8F63.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 609,249,000 United States dollar | superseded | [clm_9E12313D6BBE](/claim/clm_9E12313D6BBE.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -1,093,654,000 United States dollar | superseded | [clm_A26E8615E573](/claim/clm_A26E8615E573.md) - 2022-06-30 to 2022-09-30 | total_assets | 105,468,243,000 United States dollar | superseded | [clm_AAC722953BED](/claim/clm_AAC722953BED.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 808,325,000 United States dollar | superseded | [clm_B70E65A0C267](/claim/clm_B70E65A0C267.md) - 2022-09-30 to 2022-12-31 | total_assets | 111,168,363,000 United States dollar | superseded | [clm_35AD5817AA64](/claim/clm_35AD5817AA64.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 5,006,584,000 United States dollar | superseded | [clm_63EA4B915AD7](/claim/clm_63EA4B915AD7.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 556,338,000 United States dollar | superseded | [clm_70CE689B2252](/claim/clm_70CE689B2252.md) - 2022-09-30 to 2022-12-31 | total_equity | 5,626,315,000 United States dollar | superseded | [clm_9CDDCB344F3A](/claim/clm_9CDDCB344F3A.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 590,339,000 United States dollar | superseded | [clm_A4027CC9D53D](/claim/clm_A4027CC9D53D.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -556,484,000 United States dollar | superseded | [clm_ACFAB1AA4A08](/claim/clm_ACFAB1AA4A08.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -544,635,000 United States dollar | superseded | [clm_D4469FA0E470](/claim/clm_D4469FA0E470.md) - 2022-12-31 to 2023-12-31 | operating_income | -2,710,208,000 United States dollar | superseded | [clm_006BB618ABB5](/claim/clm_006BB618ABB5.md) - 2022-12-31 to 2023-03-31 | total_assets | 89,724,873,000 United States dollar | superseded | [clm_6F95C9D10AA4](/claim/clm_6F95C9D10AA4.md) - 2022-12-31 to 2023-12-31 | net_income | -2,624,949,000 United States dollar | superseded | [clm_7E3C47D2D6EA](/claim/clm_7E3C47D2D6EA.md) - 2022-12-31 to 2023-12-31 | research_and_development | 2,326,354,000 United States dollar | superseded | [clm_C4F355869768](/claim/clm_C4F355869768.md) - 2022-12-31 to 2023-12-31 | revenue | 3,194,208,000 United States dollar | superseded | [clm_C6565CC92BC1](/claim/clm_C6565CC92BC1.md) - 2022-12-31 to 2023-03-31 | total_equity | 5,454,557,000 United States dollar | superseded | [clm_E601789CA721](/claim/clm_E601789CA721.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 4,425,021,000 United States dollar | superseded | [clm_E65CC1452322](/claim/clm_E65CC1452322.md) ## 2023 - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 358,031,000 United States dollar | superseded | [clm_0E6EC639C067](/claim/clm_0E6EC639C067.md) - 2023-03-31 to 2023-06-30 | total_equity | 5,674,946,000 United States dollar | superseded | [clm_165CA3DF69A0](/claim/clm_165CA3DF69A0.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -123,875,000 United States dollar | superseded | [clm_432D26C3E6FA](/claim/clm_432D26C3E6FA.md) - 2023-03-31 to 2023-06-30 | total_assets | 139,301,859,000 United States dollar | superseded | [clm_69B8AEA4259F](/claim/clm_69B8AEA4259F.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 772,529,000 United States dollar | superseded | [clm_7A8A6312F126](/claim/clm_7A8A6312F126.md) - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 5,018,409,000 United States dollar | superseded | [clm_A16015D81031](/claim/clm_A16015D81031.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -78,896,000 United States dollar | superseded | [clm_BE11468E72C9](/claim/clm_BE11468E72C9.md) - 2023-06-30 to 2023-09-30 | total_equity | 5,754,703,000 United States dollar | superseded | [clm_3324B8FF1518](/claim/clm_3324B8FF1518.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 320,667,000 United States dollar | superseded | [clm_4ABB6F2D90B8](/claim/clm_4ABB6F2D90B8.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -97,405,000 United States dollar | superseded | [clm_6DE32E56B1C1](/claim/clm_6DE32E56B1C1.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 707,911,000 United States dollar | superseded | [clm_7BE315F0FB46](/claim/clm_7BE315F0FB46.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 5,166,733,000 United States dollar | superseded | [clm_8B51C4EB6346](/claim/clm_8B51C4EB6346.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -73,575,000 United States dollar | superseded | [clm_FD7A7E5B434B](/claim/clm_FD7A7E5B434B.md) - 2023-06-30 to 2023-09-30 | total_assets | 137,650,575,000 United States dollar | superseded | [clm_FDE0D864C62B](/claim/clm_FDE0D864C62B.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -79,825,000 United States dollar | superseded | [clm_06D71DF1EEB0](/claim/clm_06D71DF1EEB0.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 674,148,000 United States dollar | superseded | [clm_2BE96C7B5D8C](/claim/clm_2BE96C7B5D8C.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -2,265,000 United States dollar | superseded | [clm_4A7D43F0A50E](/claim/clm_4A7D43F0A50E.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 5,100,799,000 United States dollar | superseded | [clm_588F4F8F5486](/claim/clm_588F4F8F5486.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 322,756,000 United States dollar | superseded | [clm_7A3EC3AF89FC](/claim/clm_7A3EC3AF89FC.md) - 2023-09-30 to 2023-12-31 | total_assets | 127,305,595,000 United States dollar | superseded | [clm_CD8565298CEA](/claim/clm_CD8565298CEA.md) - 2023-09-30 to 2023-12-31 | total_equity | 5,921,125,000 United States dollar | superseded | [clm_F1D9FF28DF65](/claim/clm_F1D9FF28DF65.md) - 2023-12-31 to 2024-12-31 | operating_income | -161,662,000 United States dollar | superseded | [clm_08714B23FDB9](/claim/clm_08714B23FDB9.md) - 2023-12-31 to 2024-03-31 | total_equity | 6,281,649,000 United States dollar | superseded | [clm_407254524FF6](/claim/clm_407254524FF6.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 5,139,351,000 United States dollar | superseded | [clm_61E0539DB560](/claim/clm_61E0539DB560.md) - 2023-12-31 to 2024-03-31 | total_assets | 206,982,953,000 United States dollar | superseded | [clm_71DBE02980D2](/claim/clm_71DBE02980D2.md) - 2023-12-31 to 2024-12-31 | research_and_development | 1,324,541,000 United States dollar | superseded | [clm_793E59EBDB25](/claim/clm_793E59EBDB25.md) - 2023-12-31 to 2024-12-31 | revenue | 3,108,383,000 United States dollar | superseded | [clm_9239F28D59D7](/claim/clm_9239F28D59D7.md) - 2023-12-31 to 2024-12-31 | net_income | 94,871,000 United States dollar | superseded | [clm_EC8793EC06DD](/claim/clm_EC8793EC06DD.md) ## 2024 - 2024-03-31 to 2024-06-30 | quarterly_operating_income | 760,461,000 United States dollar | superseded | [clm_0666AA2F2843](/claim/clm_0666AA2F2843.md) - 2024-03-31 to 2024-06-30 | total_assets | 348,036,477,000 United States dollar | superseded | [clm_179FD949954B](/claim/clm_179FD949954B.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 357,863,000 United States dollar | superseded | [clm_48F10D10DB8D](/claim/clm_48F10D10DB8D.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | 1,176,245,000 United States dollar | superseded | [clm_5AE29E599CC8](/claim/clm_5AE29E599CC8.md) - 2024-03-31 to 2024-06-30 | total_equity | 8,070,994,000 United States dollar | superseded | [clm_64B56937340E](/claim/clm_64B56937340E.md) - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 6,711,400,000 United States dollar | superseded | [clm_B46BACEFFE44](/claim/clm_B46BACEFFE44.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 1,637,570,000 United States dollar | superseded | [clm_ECF9DBF45AC8](/claim/clm_ECF9DBF45AC8.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 364,258,000 United States dollar | superseded | [clm_0A3FEBA13C2D](/claim/clm_0A3FEBA13C2D.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 1,449,628,000 United States dollar | superseded | [clm_1FD52401EA32](/claim/clm_1FD52401EA32.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 7,225,535,000 United States dollar | superseded | [clm_29B0D4A722BC](/claim/clm_29B0D4A722BC.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | 36,150,000 United States dollar | superseded | [clm_616F358EBEAA](/claim/clm_616F358EBEAA.md) - 2024-06-30 to 2024-09-30 | total_assets | 286,959,173,000 United States dollar | superseded | [clm_A7693C684019](/claim/clm_A7693C684019.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | 343,117,000 United States dollar | superseded | [clm_EDEE4E6F57F7](/claim/clm_EDEE4E6F57F7.md) - 2024-06-30 to 2024-09-30 | total_equity | 8,370,769,000 United States dollar | superseded | [clm_F4FFA8A85B87](/claim/clm_F4FFA8A85B87.md) - 2024-07-24 | board_member | Christa Davies | valid | [clm_1FECC153B8E4](/claim/clm_1FECC153B8E4.md) - 2024-07-24 | board_member | Paul Clement | valid | [clm_2679211EF4AA](/claim/clm_2679211EF4AA.md) - 2024-07-24 | board_member | Chris Lehane | valid | [clm_64FDFA2A2008](/claim/clm_64FDFA2A2008.md) - 2024-09-30 to 2024-12-31 | total_assets | 290,558,608,000 United States dollar | superseded | [clm_0D830E339EC4](/claim/clm_0D830E339EC4.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | 75,495,000 United States dollar | superseded | [clm_1569847237C1](/claim/clm_1569847237C1.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 1,205,193,000 United States dollar | superseded | [clm_28405144412B](/claim/clm_28405144412B.md) - 2024-09-30 to 2024-12-31 | total_equity | 8,728,122,000 United States dollar | superseded | [clm_4A990649E8FB](/claim/clm_4A990649E8FB.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 377,440,000 United States dollar | superseded | [clm_7D8D5B4E39B0](/claim/clm_7D8D5B4E39B0.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | 169,513,000 United States dollar | superseded | [clm_E1627215B971](/claim/clm_E1627215B971.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 7,723,806,000 United States dollar | superseded | [clm_ECCD72BF093A](/claim/clm_ECCD72BF093A.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 8,543,903,000 United States dollar | superseded | [clm_3A424B5A6F0A](/claim/clm_3A424B5A6F0A.md) - 2024-12-31 to 2025-12-31 | operating_income | 2,307,160,000 United States dollar | superseded | [clm_54EA048A27D9](/claim/clm_54EA048A27D9.md) - 2024-12-31 to 2025-03-31 | total_assets | 22,541,951,000 United States dollar | superseded | [clm_77E2DADD4D98](/claim/clm_77E2DADD4D98.md) - 2024-12-31 to 2025-12-31 | revenue | 6,564,028,000 United States dollar | superseded | [clm_9AD835D976F3](/claim/clm_9AD835D976F3.md) - 2024-12-31 to 2025-12-31 | net_income | 2,579,066,000 United States dollar | superseded | [clm_B14EF4015E92](/claim/clm_B14EF4015E92.md) - 2024-12-31 to 2025-12-31 | research_and_development | 1,468,252,000 United States dollar | superseded | [clm_E136A31C09C1](/claim/clm_E136A31C09C1.md) - 2024-12-31 to 2025-03-31 | total_equity | 10,276,842,000 United States dollar | superseded | [clm_ECEF1C81DC15](/claim/clm_ECEF1C81DC15.md) ## 2025 - 2025-03-31 to 2025-06-30 | quarterly_revenue | 2,034,295,000 United States dollar | superseded | [clm_046680AD6339](/claim/clm_046680AD6339.md) - 2025-03-31 to 2025-06-30 | total_assets | 21,731,006,000 United States dollar | superseded | [clm_27FE29CA5EE8](/claim/clm_27FE29CA5EE8.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | 65,608,000 United States dollar | superseded | [clm_5F40E5586BBD](/claim/clm_5F40E5586BBD.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 355,368,000 United States dollar | superseded | [clm_B94F352A0A5C](/claim/clm_B94F352A0A5C.md) - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 8,051,169,000 United States dollar | superseded | [clm_D71245C6D0F6](/claim/clm_D71245C6D0F6.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | 705,806,000 United States dollar | superseded | [clm_D8736C8CCD40](/claim/clm_D8736C8CCD40.md) - 2025-03-31 to 2025-06-30 | total_equity | 10,468,240,000 United States dollar | superseded | [clm_FA55DE881649](/claim/clm_FA55DE881649.md) - 2025-05-08 | agreement | Deribit | valid | [clm_72A690D4E6AE](/claim/clm_72A690D4E6AE.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | 1,428,900,000 United States dollar | superseded | [clm_1D578CAB7772](/claim/clm_1D578CAB7772.md) - 2025-06-30 to 2025-09-30 | total_equity | 12,094,889,000 United States dollar | superseded | [clm_41B444F04678](/claim/clm_41B444F04678.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 7,539,388,000 United States dollar | superseded | [clm_87CF403408F9](/claim/clm_87CF403408F9.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | -24,650,000 United States dollar | superseded | [clm_CF3DFD6A1BF1](/claim/clm_CF3DFD6A1BF1.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 387,322,000 United States dollar | superseded | [clm_E4CBEF0EF518](/claim/clm_E4CBEF0EF518.md) - 2025-06-30 to 2025-09-30 | total_assets | 23,476,038,000 United States dollar | superseded | [clm_F14D829122C0](/claim/clm_F14D829122C0.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 1,497,208,000 United States dollar | superseded | [clm_F8C3DA7FA1CB](/claim/clm_F8C3DA7FA1CB.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | 480,532,000 United States dollar | superseded | [clm_21B94F087C38](/claim/clm_21B94F087C38.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 430,585,000 United States dollar | superseded | [clm_3EE0257E62CB](/claim/clm_3EE0257E62CB.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 8,676,275,000 United States dollar | superseded | [clm_50F7E936A142](/claim/clm_50F7E936A142.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 1,868,693,000 United States dollar | superseded | [clm_9F99D3DACE53](/claim/clm_9F99D3DACE53.md) - 2025-09-30 to 2025-12-31 | total_assets | 31,351,367,000 United States dollar | superseded | [clm_B19483F4F2F1](/claim/clm_B19483F4F2F1.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | 432,552,000 United States dollar | superseded | [clm_BE266E5EB125](/claim/clm_BE266E5EB125.md) - 2025-09-30 to 2025-12-31 | total_equity | 16,023,224,000 United States dollar | superseded | [clm_F9AB28667C19](/claim/clm_F9AB28667C19.md) - 2025-12-31 | revenue | 7,181,325,000 United States dollar | valid | [clm_2A00C0611BFD](/claim/clm_2A00C0611BFD.md) - 2025-12-31 to 2026-03-31 | total_equity | 14,793,058,000 United States dollar | superseded | [clm_4A5B30D052D5](/claim/clm_4A5B30D052D5.md) - 2025-12-31 | operating_income | 1,435,441,000 United States dollar | valid | [clm_578B8399D7BD](/claim/clm_578B8399D7BD.md) - 2025-12-31 | employees | 4,951 | valid | [clm_8CE8A9609BFF](/claim/clm_8CE8A9609BFF.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 11,285,452,000 United States dollar | superseded | [clm_9F9151327660](/claim/clm_9F9151327660.md) - 2025-12-31 to 2026-03-31 | total_assets | 29,671,832,000 United States dollar | superseded | [clm_A876BF8F03C4](/claim/clm_A876BF8F03C4.md) - 2025-12-31 | research_and_development | 1,670,605,000 United States dollar | valid | [clm_C22FBEE92117](/claim/clm_C22FBEE92117.md) - 2025-12-31 | net_income | 1,260,327,000 United States dollar | valid | [clm_E340E471E971](/claim/clm_E340E471E971.md) ## 2026 - 2026-03-31 to 2026-06-30 | quarterly_operating_income | -21,421,000 United States dollar | superseded | [clm_07949144F0BB](/claim/clm_07949144F0BB.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 525,648,000 United States dollar | superseded | [clm_0FE160FE9C4F](/claim/clm_0FE160FE9C4F.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -394,117,000 United States dollar | superseded | [clm_24501A278335](/claim/clm_24501A278335.md) - 2026-03-31 to 2026-06-30 | total_assets | 28,848,792,000 United States dollar | superseded | [clm_430FA596DD3F](/claim/clm_430FA596DD3F.md) - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 10,205,022,000 United States dollar | superseded | [clm_B9CDAA496FC9](/claim/clm_B9CDAA496FC9.md) - 2026-03-31 to 2026-06-30 | total_equity | 13,480,573,000 United States dollar | superseded | [clm_C15EE1FF664C](/claim/clm_C15EE1FF664C.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,412,982,000 United States dollar | superseded | [clm_C6F906700CBE](/claim/clm_C6F906700CBE.md) - 2026-05-05 | restructuring | Workforce reduction of about 700 employees to manage costs and optimize for AI era | valid | [clm_68C8A98D579B](/claim/clm_68C8A98D579B.md) - 2026-06-23 | adopted | [Cursor](/record/cursor.md) | valid | [clm_B0E90320319D](/claim/clm_B0E90320319D.md) - 2026-06-30 | total_assets | 26,460,286,000 United States dollar | valid | [clm_1DBE5C2B2AC6](/claim/clm_1DBE5C2B2AC6.md) - 2026-06-30 | quarterly_operating_income | -113,488,000 United States dollar | valid | [clm_22BD1646EFBC](/claim/clm_22BD1646EFBC.md) - 2026-06-30 | cash_and_equivalents | 8,614,065,000 United States dollar | valid | [clm_7CF4CF9973AE](/claim/clm_7CF4CF9973AE.md) - 2026-06-30 | quarterly_revenue | 1,220,068,000 United States dollar | valid | [clm_97C2BC94CFFB](/claim/clm_97C2BC94CFFB.md) - 2026-06-30 | quarterly_net_income | -359,468,000 United States dollar | valid | [clm_ADA9506179AA](/claim/clm_ADA9506179AA.md) - 2026-06-30 | quarterly_research_and_development | 472,848,000 United States dollar | valid | [clm_F2CDA39B47B1](/claim/clm_F2CDA39B47B1.md) - 2026-06-30 | total_equity | 13,079,665,000 United States dollar | valid | [clm_F55BD8373B79](/claim/clm_F55BD8373B79.md) - 2026-09-01 | board_member | Anthony Armstrong | valid | [clm_DB5E11CC7764](/claim/clm_DB5E11CC7764.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.